BSE filing, NSE: JHANDEWALAS. Summary written from the filing by ALFA Finder's alert engine.
Jhandewalas Foods Ltd: key numbers
- Share price
- ₹20.38
- Market cap
- ₹31.22 Cr
- Revenue (annual)
- ₹175.2 Cr
- Net profit (annual)
- ₹6.04 Cr
- P/E (TTM)
- 5.2×Sector 38.6×
- Promoter holding
- 55.27%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jhandewalas Foods Ltd
All →Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Jhandewalas Foods Management Change
Jhandewalas Foods Limited reported the resignation of Shipra Gandhi as Company Secretary and Compliance Officer, effective June 16, 2026, citing personal reasons.
Jhandewalas Foods Price Movement Clarification
Jhandewalas Foods Limited has responded to an exchange query, stating it is unaware of any specific reasons for recent share price movements, which are market-driven.
Jhandewalas Foods Annual General Meeting
Jhandewalas Foods Limited received ROC approval for a three-month extension to hold its Annual General Meeting. The meeting for FY 2025-26 can now be convened by December 31, 2026.
Jhandewalas Foods Board Meeting Outcome
Jhandewalas Foods Limited's board approved seeking an extension from the ROC for its FY26 Annual General Meeting. This follows the non-convening of the meeting originally scheduled for July 2026.
Jhandewalas Foods Board Meeting Date
Jhandewalas Foods Limited has scheduled a board meeting for September 30, 2026, to discuss the extension of the Annual General Meeting for the financial year 2025-26.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.